← Neo Corporate Pcl overview

Neo Corporate Pcl vs LOréal: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Neo Corporate Pcl (NEO.BK)

Q3 2026
▲2▼2

Neo Corp Q3: Stimulus Drives Record Sales, But Valuation and Q4 Risks Loom

  • Record Q3 sales and profit surge Thailand's Thai Chai Thai Plus stimulus scheme covering 40 million recipients is a major tailwind, with analysts expecting record Q3 sales of 3.2 billion baht and profit up 261–321%.

    This is the main positive force driving Neo's Q3 performance.

  • Margin support from cost cuts and partnerships Price hikes, falling palm kernel oil costs, and new BASF partnerships support margins and future growth.

    These factors improve profitability and strategic position.

  • Downgrade on valuation concerns After a 14% four-week rally, KGI downgraded NEO to hold, citing full valuation and priced-in Q3 results.

    This reflects a shift in analyst sentiment that could cap price gains.

  • Q4 profit may decline from Q3 peak Q4 profit may decline from Q3's peak due to flooding and new factory depreciation, limiting near-term upside.

    This introduces a potential headwind for the next quarter.

September 2026
▲3▼1

NEO's profit surge and stimulus lift targets, but valuation now looks full

  • Government stimulus drives record sales and profit Thailand's Thai Chai Thai Plus co-payment scheme, extended through November, is boosting NEO's sales because 92% of its revenue comes from domestic consumer products. Analysts expect record third-quarter sales of 3.2 billion baht and profit up 261-321% from a year earlier, as the scheme puts money in shoppers' hands.

    This is the main force behind NEO's earnings surge and repeated target price hikes.

  • Price increases and lower costs lift profit margins NEO raised prices on some products by 4-5% in July and targets a gross margin of 37-39%. A 7% month-on-month fall in palm kernel oil costs also helps. Analysts expect third-quarter gross margin around 38%, supporting profit growth even as sales rise.

    Margin expansion is a key reason profit is growing faster than sales.

  • New products and partnerships support future growth NEO is teaming up with BASF to develop personal care ingredients and is pushing its brands into lifestyle items for younger consumers through collaborations. These moves aim to keep sales growing after the stimulus ends, though their impact will take time to show.

    These initiatives address longer-term growth beyond the current stimulus boost.

  • Valuation looks full after strong run; one broker downgrades to hold NEO shares have risen about 14% in four weeks, and KGI downgraded the stock to hold, saying the market has already priced in the strong third-quarter results. Fourth-quarter profit may also fall from the third-quarter peak due to flooding and new factory depreciation. This limits near-term upside.

    It is the main counterweight: good news is already reflected in the price, so further gains may be limited.

Latest
▲3▼1

NEO's profit surge and stimulus lift targets, but valuation now looks full

  • Government stimulus drives record sales and profit Thailand's Thai Chai Thai Plus co-payment scheme, extended through November, is boosting NEO's sales because 92% of its revenue comes from domestic consumer products. Analysts expect record third-quarter sales of 3.2 billion baht and profit up 261-321% from a year earlier, as the scheme puts money in shoppers' hands.

    This is the main force behind NEO's earnings surge and repeated target price hikes.

  • Price increases and lower costs lift profit margins NEO raised prices on some products by 4-5% in July and targets a gross margin of 37-39%. A 7% month-on-month fall in palm kernel oil costs also helps. Analysts expect third-quarter gross margin around 38%, supporting profit growth even as sales rise.

    Margin expansion is a key reason profit is growing faster than sales.

  • New products and partnerships support future growth NEO is teaming up with BASF to develop personal care ingredients and is pushing its brands into lifestyle items for younger consumers through collaborations. These moves aim to keep sales growing after the stimulus ends, though their impact will take time to show.

    These initiatives address longer-term growth beyond the current stimulus boost.

  • Valuation looks full after strong run; one broker downgrades to hold NEO shares have risen about 14% in four weeks, and KGI downgraded the stock to hold, saying the market has already priced in the strong third-quarter results. Fourth-quarter profit may also fall from the third-quarter peak due to flooding and new factory depreciation. This limits near-term upside.

    It is the main counterweight: good news is already reflected in the price, so further gains may be limited.

August 2026
▲3

NEO's profit surge and stimulus extension keep growth story alive

  • Q2 profit jumps 161%, sales hit record NEO's second-quarter profit surged 161% to 209 million baht, with record sales of 3.05 billion baht, up 18% from a year earlier. The company raised its full-year sales growth target to double digits, showing strong momentum in household and personal care products.

    This is the core earnings event that shows the company's fundamental strength and supports the stock's value.

  • Government stimulus extension to boost Q4 demand Thailand's cabinet approved a two-month extension of the Thai Chai Thai Plus co-payment scheme, injecting up to 70 billion baht into the economy. NEO is named a top beneficiary because its consumer products are sold through traditional retail channels used by the program's 40 million recipients.

    This directly supports NEO's domestic sales and profit in the fourth quarter, a key driver of future earnings.

  • Brokers raise targets, see profit growth ahead Dao Securities maintains a Buy rating with a 31 baht target, expecting 2026 profit to grow 14% to 642 million baht. It notes the stock trades at only 11.2 times earnings, below its historical average, and does not yet reflect the profit recovery trend.

    Analyst upgrades and attractive valuation can draw investor attention and support the share price.

▲3

NEO's profit surge and stimulus extension keep growth story alive

  • Q2 profit jumps 161%, sales hit record NEO's second-quarter profit surged 161% to 209 million baht, with record sales of 3.05 billion baht, up 18% from a year earlier. The company raised its full-year sales growth target to double digits, showing strong momentum in household and personal care products.

    This is the core earnings event that shows the company's fundamental strength and supports the stock's value.

  • Government stimulus extension to boost Q4 demand Thailand's cabinet approved a two-month extension of the Thai Chai Thai Plus co-payment scheme, injecting up to 70 billion baht into the economy. NEO is named a top beneficiary because its consumer products are sold through traditional retail channels used by the program's 40 million recipients.

    This directly supports NEO's domestic sales and profit in the fourth quarter, a key driver of future earnings.

  • Brokers raise targets, see profit growth ahead Dao Securities maintains a Buy rating with a 31 baht target, expecting 2026 profit to grow 14% to 642 million baht. It notes the stock trades at only 11.2 times earnings, below its historical average, and does not yet reflect the profit recovery trend.

    Analyst upgrades and attractive valuation can draw investor attention and support the share price.

LOréal S.A. (OR.PA)

Q3 2026
▲3

L'Oréal gains on beauty shift, deals, and AI marketing

  • Strong H1 results and record margin H1 sales rose 6.5% like-for-like to €23.77bn with a record 21.3% operating margin, and Q2 beat expectations on haircare and mascara demand, showing resilient consumer appetite.

    This explains the fundamental strength that supported the stock during the period.

  • Strategic acquisitions and license wins L'Oréal secured the Gucci beauty license early, acquired Kering's beauty division for $4.7bn, Innovist and Onesto Labs, and is eyeing an Armani stake, expanding its brand portfolio.

    These deals are major strategic moves that could drive future growth and were new in the period.

  • Chinese consumers shift to premium beauty Chinese consumers are moving from luxury fashion to premium beauty, helping L'Oréal overtake LVMH as France's most valuable listed company, a significant market shift.

    This consumer trend directly boosted L'Oréal's relative valuation and market position.

  • AI marketing and bond raise, but risks remain AI now drives ~20% of marketing and a €2bn bond adds flexibility, but luxury missed forecasts, travel retail remains weak, and dealmaking plus the bond raise carry integration and leverage risks.

    This captures both the efficiency gains and the real counterweights that could pressure the stock.

September 2026
▲4

L'Oréal gains from China beauty shift, dealmaking and AI push

  • Chinese consumers shift to premium beauty Chinese shoppers are cutting back on luxury fashion but still buying premium skincare and cosmetics. L'Oréal's luxury beauty division in China grew 10% last quarter, and 37% of high-spending Chinese consumers plan to spend more on beauty next year. This supports demand for OR.PA.

    This is a core demand driver showing why L'Oréal is outperforming luxury peers in a key market.

  • L'Oréal becomes France's most valuable listed company L'Oréal overtook LVMH as France's most valuable listed company, helped by the 'lipstick effect' — when money is tight, people still treat themselves to affordable beauty items. L'Oréal shares are up about 5% this year while LVMH is down 35%, showing a clear investor preference for beauty over high fashion.

    This milestone reflects the market's recognition of L'Oréal's relative strength and the shift in consumer spending.

  • Dealmaking spree: Kering beauty, Onesto Labs, Armani stake L'Oréal bought Kering's beauty division for $4.7 billion, won approval to buy India's Onesto Labs, and is in talks for a minority stake in Giorgio Armani. These moves expand its luxury and consumer brands, deepen its fragrance and cosmetics reach, and add growth in India. They strengthen future earnings power.

    These deals are major capital actions that expand L'Oréal's portfolio and market reach, directly affecting its growth outlook.

  • AI-led marketing and €2bn bond for flexibility L'Oréal says nearly 20% of its marketing spend is now AI-led, improving efficiency and consumer targeting. It also priced a €2 billion bond to fund general corporate needs, giving it cheap, long-term money. Both support profit margins and future investments.

    These show operational efficiency gains and financial strength, which underpin the company's ability to grow and invest.

Latest
▲4

L'Oréal gains from China beauty shift, dealmaking and AI push

  • Chinese consumers shift to premium beauty Chinese shoppers are cutting back on luxury fashion but still buying premium skincare and cosmetics. L'Oréal's luxury beauty division in China grew 10% last quarter, and 37% of high-spending Chinese consumers plan to spend more on beauty next year. This supports demand for OR.PA.

    This is a core demand driver showing why L'Oréal is outperforming luxury peers in a key market.

  • L'Oréal becomes France's most valuable listed company L'Oréal overtook LVMH as France's most valuable listed company, helped by the 'lipstick effect' — when money is tight, people still treat themselves to affordable beauty items. L'Oréal shares are up about 5% this year while LVMH is down 35%, showing a clear investor preference for beauty over high fashion.

    This milestone reflects the market's recognition of L'Oréal's relative strength and the shift in consumer spending.

  • Dealmaking spree: Kering beauty, Onesto Labs, Armani stake L'Oréal bought Kering's beauty division for $4.7 billion, won approval to buy India's Onesto Labs, and is in talks for a minority stake in Giorgio Armani. These moves expand its luxury and consumer brands, deepen its fragrance and cosmetics reach, and add growth in India. They strengthen future earnings power.

    These deals are major capital actions that expand L'Oréal's portfolio and market reach, directly affecting its growth outlook.

  • AI-led marketing and €2bn bond for flexibility L'Oréal says nearly 20% of its marketing spend is now AI-led, improving efficiency and consumer targeting. It also priced a €2 billion bond to fund general corporate needs, giving it cheap, long-term money. Both support profit margins and future investments.

    These show operational efficiency gains and financial strength, which underpin the company's ability to grow and invest.

July 2026
▲4

L'Oréal beats forecasts, buys growth, and adds Gucci beauty

  • H1 results beat expectations with record margin L'Oréal's first-half sales rose 6.5% like-for-like to €23.77bn, with a record 21.3% operating margin. All four divisions grew, led by Professional Products and Dermatological Beauty. Strong profit and broad-based growth support a higher share price.

    This is the core earnings event that directly drives investor confidence and valuation.

  • Q2 sales beat forecasts on haircare and mascara demand Second-quarter like-for-like sales rose 6.3%, beating the 5.7% consensus, with Europe up 6.7% and North America up 5.9%. Luxury missed forecasts but China showed double-digit growth. The beat signals resilient consumer demand despite travel retail weakness.

    It confirms the growth trend and shows demand is holding up in key regions.

  • Gucci beauty license starts early, expanding prestige portfolio Coty will exit its Gucci beauty license a year early, letting L'Oréal begin a 50-year exclusive license from July 2027. L'Oréal covers about 70% of Coty's early redemption costs. This adds a major luxury brand to its prestige lineup.

    It is a new, long-term revenue stream that strengthens L'Oréal's luxury division.

  • Acquires Innovist in India and eyes Armani stake L'Oréal agreed to buy a majority stake in Indian digital-first personal care house Innovist, adding brands like Bare Anatomy. It is also named as a possible buyer of a stake in Giorgio Armani Group. Both moves expand reach in fast-growing markets and prestige.

    These deals show management actively deploying capital for future growth.

▲4

L'Oréal beats forecasts, buys growth, and adds Gucci beauty

  • H1 results beat expectations with record margin L'Oréal's first-half sales rose 6.5% like-for-like to €23.77bn, with a record 21.3% operating margin. All four divisions grew, led by Professional Products and Dermatological Beauty. Strong profit and broad-based growth support a higher share price.

    This is the core earnings event that directly drives investor confidence and valuation.

  • Q2 sales beat forecasts on haircare and mascara demand Second-quarter like-for-like sales rose 6.3%, beating the 5.7% consensus, with Europe up 6.7% and North America up 5.9%. Luxury missed forecasts but China showed double-digit growth. The beat signals resilient consumer demand despite travel retail weakness.

    It confirms the growth trend and shows demand is holding up in key regions.

  • Gucci beauty license starts early, expanding prestige portfolio Coty will exit its Gucci beauty license a year early, letting L'Oréal begin a 50-year exclusive license from July 2027. L'Oréal covers about 70% of Coty's early redemption costs. This adds a major luxury brand to its prestige lineup.

    It is a new, long-term revenue stream that strengthens L'Oréal's luxury division.

  • Acquires Innovist in India and eyes Armani stake L'Oréal agreed to buy a majority stake in Indian digital-first personal care house Innovist, adding brands like Bare Anatomy. It is also named as a possible buyer of a stake in Giorgio Armani Group. Both moves expand reach in fast-growing markets and prestige.

    These deals show management actively deploying capital for future growth.